Month: August 2014

“Why physicians should not accept money from the pharmaceutical industry” — Reblogged @FearLoathingBTX | +2 bonus

Original post at Fear and Loathing in Bioethics — C. Elliott “If we have learned anything from a decade’s worth of litigation, it is that the pharmaceutical industry pays the vast majority of physicians for one reason: to market their drugs. And why would we have ever thought otherwise? Pharma companies are not charitable organizations.…

“If you work in a university and you suspected wrongdoing, what would you do next?” – Reblogged @FearLoathingBTX

The Times Higher Ed Supplement has an interesting piece on university whistleblowers, including an update the notorious case of Dr. Aubrey Bluhmson, who blew the whistle on pharma-funded wrongdoing at Sheffield University. See the original post “If you work in a university and you suspected wrongdoing, what would you do next?” — Fear and Loathing…

Solo un ejemplo de algo muy frecuente en Latinoamérica: mala prensa en temas de ciencia, tecnología y salud.

Noticias en “Google News” sobre papiloma En Colombia el periodismo científico por parte de todos los medios (impresos y audiovisuales)  es de pésima calidad y causa mucho daño en la sociedad. Este tipo de noticias no merecen ni siquiera ser discutidas de forma individual. Fin Déjà vu… http://www.elpais.com.co/elpais/cali/noticias/cali-prepara-para-producir-nano-agua https://chaoticpharmacology.wordpress.com/2014/08/12/a-story-about-oxygen-nanobubbles-introduction/        

Requested (Jul 29, 2014) & Retracted by the author (Aug 23, 2014): “Conelly S, et al. Dabigatran versus Warfarin in Patients with Atrial Fibrillation. N Engl J Med 2009; 361:1139-1151”] – Question Thread Open

http://figshare.com/articles/_NEJM_Boehringer_RE_LY_Pradaxa_dabigatran_3rd_request_of_retraction_AllTrials/1144305    Description August 19, 2014. 6:00AM (Bogotá time zone)  Third request of retraction: NEJM, Boehringer, Pradaxa, dabigatran, RE-LY study. (1st URL attached below). This Fileset will be continuosly updated 1- Old versions will be available in the history of this archive. 2- Changes will also be included below this comment. —————————————————————————— August 19, 2014.…

“Chaos Theory” to “Evidence Based Medicine”: Hello!

“Chaos Theory” to “Evidence Based Medicine”: see you soon: Deadline: October 31, 2014. Please let chaos knows if it is possible or not to be there by Oct 31.      (4) Cheers. . . . . . PubMed publication trends according to MeSH terms (available below) Questions on ResearchGate about the hypothesis: Closed This…

figshare: a synonym of open data

    http://figshare.com/articles/Effect…a_randomized_clinical_trial/1098548 Periodontal therapy does not improve cardiovascular disease biomarkers: results of a randomized clinical trial Periodontal therapy does not improve cardiovascular disease biomarkers: results of a randomized clinical trial  https://impactstory.org/Jorge/product/5x3bgx9kegjdcpxnupezhk4o Impactstory  https://www.researchgate.net/public…0681564_%28XML_format%29?ev=prf_pub  https://www.researchgate.net/post/A…ringer2?_tpcectx=profile_highlights Any reason not to retract this paper? NEJM – RE-LY – Pradaxa -…  http://figshare.com/articles/NEJM_a…gatran_Pradaxa_July_29_2014/1141921 NEJM & Boehringer: request to retract…

NEJM Boehringer RE-LY (#Pradaxa dabigatran) – 3rd request of retraction #AllTrials

https://twitter.com/JorgeHernnRamre/status/501686099886870529 Addendum: comments in the figshare fileset August 19, 2014. 6:00AM (Bogotá time zone) Third request of retraction: NEJM, Boehringer, Pradaxa, dabigatran, RE-LY study. (1st URL attached below). This Fileset will be continuosly updated 1- Old versions will be available in the history of this archive. 2- Changes will also be included below this comment.…